Invent Farma S.L.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Invent Farma S.L. - overview

Established

2005

Location

Barcelona, -, Spain

Primary Industry

Pharmaceuticals

About

Founded in 2005 and headquartered in Barcelona, Spain, Invent Farma S. L. operates as a pharmaceutical company that develops and manufactures active substances and generic medicinal products.


Primary Industry

Pharmaceuticals

Sub Industries

Pharmaceutical Research & Development

Website

www.invent-farma.es

Verticals

Manufacturing

Company Stage

Add-on

Total Amount Raised

Subscriber access only

Invent Farma S.L. - financials

Fiscal Year EndedDec 31, 2015Dec 31, 2016Dec 31, 2017Dec 31, 2018Dec 31, 2019
Revenue (USD)6,679,3239,937,267---
% Revenue Growth (YoY)-48.8%---
EBITDA (USD)1,560,8272,357,699---
Operating Income (USD)1,447,2272,272,896---
Operating Margin21.7%22.9%---
% EBITDA Margin23.4%23.7%---
NET Income (USD)984,989203,285,415---
% Net Margin14.7%2045.7%---

Invent Farma S.L. - deals

Deals TypeDeal StatusTarget (s)Deal DateInvestor(s)Seller(s)Deal size (Mn)Enterprise value (Mn)Post-money valuation (Mn)EBITDA multiple (x)Revenue multiple (x)Lead partner (s)
Secondary BuyoutCompletedNeuraxpharm Holdco Iberia S.L.U.-
Company FormationCompletedNeuraxpharm Holdco Iberia S.L.U.-
Add-onCompletedInvent Farma S.L.-

Displaying 1 - 3 of 3

Invent Farma S.L. - employee data

Blurred Background

Want to see Employee Count?

Request a demo for full access to this profile.

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.